GenMont Biotech Inc (3164) — Strategic Asset Allocation Index
GenMont Biotech Inc (3164) has a Strategic Asset Allocation Index of 74.4% as of June 2023. Strategic assets (PP&E of NT$1.06 Billion plus long-term investments of NT$-) total NT$1.06 Billion, measured against net assets of NT$1.42 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
GenMont Biotech Inc Strategic Asset Allocation Index (2003–2022)
This chart shows how GenMont Biotech Inc's Strategic Asset Allocation Index has evolved across 20 annual periods from 2003 to 2022. As of June 2023, the index stands at 74.4%, representing strategic assets of NT$1.06 Billion against net assets of NT$1.42 Billion TWD. Explore 3164 operating cash flow to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for GenMont Biotech Inc (2003–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for GenMont Biotech Inc from 2003 to 2022, covering 20 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 3164 company net worth.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 74.4% | NT$1.11 Billion | NT$1.11 Billion | NT$- | NT$1.50 Billion | ▲ +5.8 pp |
| 2021 | 68.6% | NT$1.05 Billion | NT$1.05 Billion | NT$- | NT$1.52 Billion | ▲ +6.3 pp |
| 2020 | 62.3% | NT$922.68 Million | NT$922.68 Million | NT$- | NT$1.48 Billion | ▲ +10.4 pp |
| 2019 | 51.8% | NT$750.55 Million | NT$750.55 Million | NT$- | NT$1.45 Billion | ▲ +26.6 pp |
| 2018 | 25.2% | NT$394.54 Million | NT$352.68 Million | NT$41.85 Million | NT$1.56 Billion | ▼ -40.8 pp |
| 2017 | 66.1% | NT$905.60 Million | NT$865.25 Million | NT$40.35 Million | NT$1.37 Billion | ▼ -4.6 pp |
| 2016 | 70.7% | NT$904.63 Million | NT$866.70 Million | NT$37.94 Million | NT$1.28 Billion | ▲ +10.1 pp |
| 2015 | 60.5% | NT$908.47 Million | NT$884.58 Million | NT$23.89 Million | NT$1.50 Billion | ▲ +1.5 pp |
| 2014 | 59.1% | NT$943.39 Million | NT$920.00 Million | NT$23.39 Million | NT$1.60 Billion | ▲ +42.9 pp |
| 2013 | 16.1% | NT$134.99 Million | NT$117.67 Million | NT$17.32 Million | NT$837.28 Million | ▲ +1.2 pp |
| 2012 | 15.0% | NT$128.97 Million | NT$128.97 Million | NT$- | NT$861.62 Million | ▼ -1.6 pp |
| 2011 | 16.5% | NT$149.46 Million | NT$149.46 Million | NT$- | NT$904.75 Million | ▼ -6.5 pp |
| 2010 | 23.0% | NT$169.63 Million | NT$169.63 Million | NT$- | NT$737.87 Million | ▼ -4.0 pp |
| 2009 | 27.0% | NT$171.67 Million | NT$171.67 Million | NT$- | NT$635.68 Million | ▼ -0.7 pp |
| 2008 | 27.7% | NT$168.78 Million | NT$168.78 Million | NT$- | NT$609.60 Million | ▼ -0.1 pp |
| 2007 | 27.8% | NT$145.63 Million | NT$145.63 Million | NT$- | NT$524.64 Million | ▲ +7.1 pp |
| 2006 | 20.7% | NT$95.54 Million | NT$95.54 Million | NT$- | NT$461.75 Million | ▼ -15.8 pp |
| 2005 | 36.5% | NT$106.00 Million | NT$106.00 Million | NT$- | NT$290.14 Million | ▼ -2.9 pp |
| 2004 | 39.5% | NT$116.11 Million | NT$116.11 Million | NT$- | NT$294.16 Million | ▼ -8.6 pp |
| 2003 | 48.1% | NT$119.55 Million | NT$119.55 Million | NT$- | NT$248.64 Million | — |